Supplementary Figure 3-1 from Erlotinib Prolongs Survival in Pancreatic Cancer by Blocking Gemcitabine-Induced MAPK Signals

crossref(2023)

引用 0|浏览6
暂无评分
摘要

Supplementary Figure 3-1 PDF file - 354K, Gemcitabine-induced expression of EGFR ligands was dependent on active MAPK signaling in the PDAC cells

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要